Inhaled corticosteroids: benefits and risks.
Open Access
- 1 June 1992
- Vol. 47 (6), 404-407
- https://doi.org/10.1136/thx.47.6.404
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing HormoneNew England Journal of Medicine, 1992
- Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthmaAllergy, 1989
- Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonideJournal of Allergy and Clinical Immunology, 1988
- A double‐blind dose‐response study of budesonide by inhalation in patients with bronchial asthmaAllergy, 1988
- A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthmaRespiratory Medicine, 1987
- Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.Thorax, 1987
- Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.Thorax, 1986
- Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: Assessment of relative prednisolone-sparing effectsRespiratory Medicine, 1985
- Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in chronic bronchial asthmaRespiratory Medicine, 1979
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973